Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Rite-Diet gluten free fibre bread sliced
0904010H0BEABAA
|
Rite-Diet (Gluten free bread) | Gluten free breads | Nutrition and Blood | No data available |
|
Rite-Diet gluten free fibre bread unsliced
0904010H0BEAEAA
|
Rite-Diet (Gluten free bread) | Gluten free breads | Nutrition and Blood | No data available |
|
Rite-Diet gluten free fibre rolls
0904010H0BEADAA
|
Rite-Diet (Gluten free bread) | Gluten free breads | Nutrition and Blood | No data available |
|
Rite-Diet gluten free part baked fibre loaf
0904010H0BEAIAA
|
Rite-Diet (Gluten free bread) | Gluten free breads | Nutrition and Blood | No data available |
|
Rite-Diet gluten free part baked long fibre rolls
0904010H0BEAJAA
|
Rite-Diet (Gluten free bread) | Gluten free breads | Nutrition and Blood | No data available |
|
Rite-Diet gluten free part baked long white rolls
0904010H0BEAHAA
|
Rite-Diet (Gluten free bread) | Gluten free breads | Nutrition and Blood | No data available |
|
Rite-Diet gluten free part baked white loaf
0904010H0BEAGAA
|
Rite-Diet (Gluten free bread) | Gluten free breads | Nutrition and Blood | No data available |
|
Rite-Diet gluten free white bread sliced
0904010H0BEAAAA
|
Rite-Diet (Gluten free bread) | Gluten free breads | Nutrition and Blood | No data available |
|
Rite-Diet gluten free white bread unsliced
0904010H0BEAFAA
|
Rite-Diet (Gluten free bread) | Gluten free breads | Nutrition and Blood | No data available |
|
Rite-Diet gluten free white rolls
0904010H0BEACAA
|
Rite-Diet (Gluten free bread) | Gluten free breads | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.